Karolinska Institute
Inify Laboratories, Karolinska Institutet Partner to Improve AI-Driven Prostate Cancer Diagnosis
The partners will use Inify's AI platform to identify potentially cancerous regions in prostate cancer biopsy images within Karolinska's ProMort program.
Akiram Therapeutics' CD44v6-Targeted Radiopharmaceutical to Enter Phase I Trials in Sweden
Swedish regulators cleared a clinical trial application, allowing Karolinska University Hospital investigators to begin studying 177Lu-AKIR001.
AstraZeneca Signs Precision Medicine Agreements With M42, Karolinska Institutet
M42 will sequence hereditary cancer genes at its Abu Dhabi facility to explore tailored care and preventive measures for patients in the Middle East.
Breast Cancer Study Informs Affibody, GE HealthCare's Development Path for HER2 Radiopharmaceutical
Premium
The PET imaging agent 68Ga-ABY-025 could have a leg up over IHC in predicting metastatic breast cancer patients' ability to respond to HER2-targeted treatment.
Cellerys Taps Neogap Therapeutics' T-Cell Detection Tech for MS Cell Therapy Trial
The upcoming Phase II trial will evaluate RED4MS, a cell therapy designed to induce antigen-specific immune tolerance for multiple sclerosis patients.